Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke

Stroke

Volumn 29, Issue 2, 1998, Pages 454-461

  Heiss, Wolf Dieter ^a   Grond, Martin ^a   Thiel, Alexander ^a   Ghaemi, Mehran ^a   Sobesky, Jan ^a   Rudolf, Jobst ^a   Bauer, Bernd ^a   Wienhard, Klaus ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Flumazenil; Receptors, benzodiazepine; Stroke, ischemic; Tomography, emission computed

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR; FLUMAZENIL;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN METABOLISM; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLUCOSE METABOLISM; HUMAN; LIGAND BINDING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE; TISSUE INJURY;

EID: 0031911242     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.2.454     Document Type: Article

References (54)

1. Krnjevic K. Neurotransmitters in cerebral cortex. In: Jones E, Peters A, eds. Cerebral Cortex, Vol 2: Functional Properties of Cortical Cells. New York, NY: Plenum Press; 1984:39-61.
2. Hantraye P, Kaijima M, Prenant C, Guibert B, Sastre J, Crouzel M, Naquet R, Comar D, Mazière M. Central type benzodiazepine binding sites: a positron emission tomography study in the baboon's brain. Neurosci Lett. 1984;48:115-117.
3. Abadie P, Baron JC. In vivo studies of the central benzodiazepine receptors in the human brain with positron emission tomography. In: Diksic M, Reba RC, eds. Radiopharmaceuticals and Brain Pathology Studies with PET and SPECT. Boca Raton, Fla: CRC Press; 1991:357-379.
4. Müller WE. The Benzodiazepine Receptor. Cambridge. England: Cambridge University Press; 1987.
5. Sadzot B, Frost JJ. Benzodiazepine receptors. In: Frost JJ, Wagner HN Jr. eds. Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes. New York, NY: Raven Press; 1990:109-127.
6. Duncan JS. Imaging and epilepsy. Brain. 1997;120:339-377.
7. Fukuchi K, Hashikawa K, Seike Y, Moriwaki H, Oku N, Ishida M, Fujita M, Uehara T, Tanabe H, Kusuoka H, Nishimura T. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease. J Nucl Med. 1997;38:467-470.
8. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barré L, Travère JM, Derlon JM, MacKenzie ET. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke. 1993;24:2046-2058.
9. Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami A, Ogawa T, Fujita H, Noguchi K, Kanno I, Miura S, Murakami M, Iida H, Miura Y, Uemura K. Evaluation of cerebral infarction with iodine-123-iomazenil SPECT. J Nucl Med. 1995;36:2154-2161.
10. Hayashida K, Hirose Y, Tanaka Y, Miyashita K, Ishida Y, Miyake Y, Nishimura T. Reduction of 1231-iomazenil uptake in haemodynamically and metabolically impaired brain areas in patients with cerebrovascular disease. Nucl Med Commun. 1996;17:701-705.
11. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke. 1997;28: 124-132.
12. Heiss W-D, Graf R, Löttgen J, Ohta K, Fujita T, Wagner R, Grond M, Wienhard K. Repeat positron emission tomographic studies in transient middle cerebral artery occlusion in cats: residual perfusion and efficacy of postischemic reperfusion. J Cereb Blood Flow Metab. 1997;17:388-400.
13. Wienhard K, Dahlbom M, Eriksson L, Michel Ch, Bruckbauer T, Pietrzyk U, Heiss W-D. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr. 1994;18:110-118.
14. Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with intravenous H2-15O, I: theory and error analysis. J Nucl Med. 1983;24: 782-789.
15. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B. Automated blood sampling systems for positron emission tomography. IEEE Trans Nucl Sci. 1988;35:703-704.
16. Mintun MA, Raichle ME, Martin WRW, Herscovitch P. Brain oxygen utilization measured with O15 radiotracers and positron emission tomography. J Nucl Med. 1984;25:177-187.
17. Heiss W-D, Huber M, Fink G, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193-203.
18. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol. 1991;30:663-672.
19. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som I, Sokoloff L. The (18F)fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44:127-137.
20. Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss W-D. Estimation of local cerebral utilization by positron emission tomography of (18F)-2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab. 1985;5:115-125.
21. Pietrzyk U, Herholz K, Fink G, Jacobs A, Mielke R, Slansky I, Würker M, Heiss W-D. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med. 1994;35:2011-2018.
22. von Stockhausen H-M, Pietrzyk U, Herholz K, Heiss W-D. Eine Methode zur oberflächenbezogenen Quantifizierung funktioneller Daten am Beispiel des menschlichen Kortex. In: Lehmann T, Scholl I, Spitzer K, eds. Bildverarbeitung in der Medizin. Aachen, Germany: Verl d Augustinus Buchhandlung; 1996:29-34.
23. Baron JC, Rougemont D, Soussaline F, Bustany P, Crouzel C, Bousser MG, Comar D. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab. 1984;4:140-149.
24. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985;5:600-608.
25. Lassen NA. Incomplete cerebral infarction: focal incomplete ischemic tissue necrosis not leading to emollision. Stroke. 1982;13:522-523.
26. Kummer R v, Meyding-Lamade U, Forsting M, Rosin L, Rieke K, Hacke W, Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994;15:9-15.
27. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231-241.
28. Schwartz RD, Yu X, Wagner J, Ehrmann M, Mileson BE. Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia. Neuropsychopharmacology. 1992;6:119-125.
29. Westerberg E, Monaghan DT, Cotman CW, Wieloch T. Excitatory amino acid receptors and ischemic brain damage in the rat. Neurosci Lett. 1987;73:119-124.
30. Dewar D, Wallace MC, Kurumaji A, McCulloch J. Alterations in the N-methyl-D-aspartate receptor complex following focal cerebral ischemia. J Cereb Blood Flow Metab. 1989;9:709-712.
31. Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P. Reversal of focal 'misery-perfusion syndrome' by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. Stroke. 1981;12:454-459.
32. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia: the isché mic penumbra. Stroke. 1981;12:723-725.
33. Heiss W-D, Fink GR, Huber M, Herholz K. Positron emission tomography imaging and the therapeutic window. Stroke. 1993;24(suppl I):I-50-I-53.
34. Furlan M, Marchal G, Viader F, Derlon J-M, Baron J-C. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-226.
35. Feeney DM, Baron JC. Diaschisis. Stroke. 1986;17:817-830.
36. Wise RJS, Bernardi S, Frackowiak RSJ, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke. Brain. 1983;106:197-222.
37. Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, Marchal G, Beil C, Pokrupa R, Diksic M, Meyer E, Gjedde A, Marrett S. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab. 1989;9:523-534.
38. Mies G, Auer LM, Ebhardt G, Traupe H, Heiss W-D. Flow and neuronal density in tissue surrounding chronic infarction. Stroke. 1983;14:22-27.
39. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 1996;27:761-765.
40. Minoshima S, Frey KA, Koeppe RA, Chimowitz MI, McCune WJ, Kuhl DE. Regional discordance between benzodiazepine receptor distribution and glucose metabolism in ischemic cerebral vascular diseases. J Nucl Med. 1993;34:207P. Abstract.
41. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol (Berl). 1984;64:139-147.
42. Garcia JH, Liu K-F, Ho K-L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke. 1995;26:636-643.
43. Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, Pozzilli C, Fieschi C. Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol. 1995;52:670-675.
44. Alexandrov AV, Grotta JC, Davis SM, Lassen NA. Brain SPECT and thrombolysis in acute ischemic stroke: time for a clinical trial. J Nucl Med. 1996;37:1259-1262.
45. Baird AE, Austin MC, McKay WJ, Donnan GA. Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome. J Neurol Neurosurg Psychiatry. 1996;61:26-29.
46. Ezura M, Takahashi A, Yoshimoto T. Evaluation of regional cerebral blood flow using single photon emission tomography for the selection of patients for local fibrinolytic therapy of acute cerebral embolism. Neurosurg Rev. 1996;19:231-236.
47. Hanson SK, Grotta JC, Rhoades H, Tran HD, Lamki LM, Barron BJ, Taylor WJ. Value of single-photon emission-computed tomography in acute stroke therapeutic trials. Stroke. 1993;24:1322-1329.
48. Herderscheé D, Limburg M, van Royen EA, Hijdra A, Büller A, Koster PA. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT. Acta Neurol Scand. 1991; 83:317-322.
49. Heiss W-D, Grond M, Thiel A, Stockhausen H-Mv, Rudolf J. Ischaemic brain tissue salvaged from infarction with alteplase. Lancet. 1997;349: 1599-1600.
50. Olsen RW. The GABA postsynaptic membrane receptor-ionophore complex. Mol Cell Biochem. 1981;39:261-279.
51. D values with positron emission tomography. Eur J Pharmacol. 1992;213:107-115.
52. Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab. 1991;11:735-744.
53. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke: summary statement. Neurology. 1996;47:835-839.
54. Baron JC, von Kummer R, del Zoppo GJ. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 1995;26:2219-2221.